Cargando…
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis
The therapeutic benefits of adrenocorticotropic hormone in multiple sclerosis are usually ascribed to its corticotropic actions. Evidence is presented that adrenocorticotropic hormone, approved for multiple sclerosis relapses, acts via corticosteroid-independent melanocortin pathways to engender dow...
Autores principales: | Arnason, Barry G, Berkovich, Regina, Catania, Anna, Lisak, Robert P, Zaidi, Mone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573675/ https://www.ncbi.nlm.nih.gov/pubmed/23034287 http://dx.doi.org/10.1177/1352458512458844 |
Ejemplares similares
-
Melanocortins, Melanocortin Receptors and Multiple Sclerosis
por: Lisak, Robert P., et al.
Publicado: (2017) -
Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone
por: Ross, Amy Perrin, et al.
Publicado: (2013) -
Melanocortin Receptor Accessory Protein 2-Induced Adrenocorticotropic Hormone Response of Human Melanocortin 4 Receptor
por: Soletto, Lucia, et al.
Publicado: (2018) -
Pregnancy, sex and hormonal factors in multiple sclerosis
por: Miller, David H, et al.
Publicado: (2014) -
Adrenocorticotropic hormone analog use for podocytopathies
por: Filippone, Edward J, et al.
Publicado: (2016)